BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7686950)

  • 1. Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.
    Panzer-Grümayer ER; Panzer S; Wolf M; Majdic O; Haas OA; Kersey JH
    J Immunol; 1993 Jul; 151(1):92-9. PubMed ID: 7686950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cells with morphological and antigenic properties of microglia from cloned EBV-transformed lymphoid progenitor cells derived from human fetal liver.
    Ichigi Y; Naitoh K; Tokushima M; Haraoka S; Tagoh H; Kimoto M; Muraguchi A
    Cell Immunol; 1993 Jun; 149(1):193-207. PubMed ID: 7685659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
    Gregory CD; Kirchgens C; Edwards CF; Young LS; Rowe M; Forster A; Rabbitts TH; Rickinson AB
    Eur J Immunol; 1987 Aug; 17(8):1199-207. PubMed ID: 3040424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression.
    Long H; Gaffney P; Mortari F; Miller JS
    Exp Hematol; 1996 Oct; 24(12):1402-8. PubMed ID: 8913286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
    Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
    J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphoblastoid cell lines with rearranged T cell receptor beta-chain genes retain conventional B cell surface antigen and Ig expression.
    Robinson MA; Kindt TJ
    J Immunol; 1988 Feb; 140(4):1327-34. PubMed ID: 2830338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties and heterogeneity of human fetal pre-B cells transformed by EBV.
    Hui MF; Lam P; Dosch HM
    J Immunol; 1989 Oct; 143(8):2470-9. PubMed ID: 2551960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways.
    Sanz E; Muñoz-A N; Monserrat J; Van-Den-Rym A; Escoll P; Ranz I; Alvarez-Mon M; de-la-Hera A
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5925-30. PubMed ID: 20231472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete TCR-delta rearrangements and partial (D-J) recombination of the TCR-beta locus in CD34+7+ precursors from human cord blood.
    Ktorza S; Blanc C; Laurent C; Sarun S; Verpilleux MP; Debré P; Schmitt C
    J Immunol; 1996 Jun; 156(11):4120-7. PubMed ID: 8666778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangement of T cell receptor beta, gamma, and delta gene loci in human pre-T cell acute lymphoblastic leukemia.
    Raghavachar A; Thiel E; Hansen-Hagge TE; Kranz B; Bartram CR
    Leukemia; 1989 Jun; 3(6):413-8. PubMed ID: 2542699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between immunogenotypic findings in de novo AML and AML post MDS.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Fujimura T; Shimamoto T; Nakazawa S; Kimura N; Toyama K
    Leukemia; 1993 Nov; 7(11):1747-51. PubMed ID: 7694003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD7 on normal human myeloid progenitors.
    Chabannon C; Wood P; Torok-Storb B
    J Immunol; 1992 Sep; 149(6):2110-3. PubMed ID: 1381397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of v-myc/v-raf-transformed murine fetal thymocyte cell lines.
    Taubenberger JK; Reid AH; Izon D; Boehme SA
    Cell Immunol; 1996 Jul; 171(1):41-7. PubMed ID: 8754860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
    Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
    J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage commitment of CD34+ human hematopoietic progenitor cells.
    Tjønnfjord GE; Steen R; Veiby OP; Egeland T
    Exp Hematol; 1996 Jul; 24(8):875-82. PubMed ID: 8690045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.